Originally presented on September 10th, 2021 as a main session at the 2021 Virtual MDF Annual Conference.

Representatives from biotech and pharma companies will provide updates on their drug development efforts in the DM field. Day 1 to feature AMO Pharma, Avidity Biosciences, Harmony Biosciences & Dyne Therapeutics.

Speakers include:

• Ibraheem Mahmood, AMO Pharma
• Elizabeth Ackermann, PhD, Avidity Biosciences
• Jeffrey M. Dayno, MD, Harmony Biosciences
• William Jacobson, PhD, Harmony Biosciences
• Ashish Dugar, PhD, Dyne Therapeutics